Business & Finance
Diagnostic tests company projects first quarter profit
Published in Health and Medicine Week, August 22nd, 2005
Based on existing contracts, current invoices and scheduled deliveries for its VScan products in the first quarter (July 05 to Sept 05) the company is projecting that it will report a profit for the first quarter of $1,130,000 US on overall revenue of $2,440,000 US.
As the existing contracts extend through the second quarter and it is anticipated that the company will obtain additional contracts, it is reasonable to expect that the company will continue to maintain or slightly exceed its first quarter pace. The time, effort and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
More Articles from Health and Medicine Week
- Adverse Drug Reaction
Importance of reporting suspected drug reactions emphasized - Exercise
Physical activity as substitute for sedentary behavior examined - HIV/AIDS Diagnosis
Ten-minute, U.S. FDA-approved HIV test developed - Lymphoma Vaccine
Tumor-derived idiotype vaccine for non-Hodgkin's lymphomas described - Tobacco Use
Mechanisms linking media to smoking in high school students reported - Abdominal Aortic Aneurysms
FDA approves Powerlink trials on AAA patients with large diameter aortic necks - More from this issue of Health and Medicine Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
